S. Guerra et al. / Tetrahedron Letters 54 (2013) 6251–6257
6257
resulting mixture was stirred overnight at room temperature. A saturated
NaHCO3 aqueous solution was added and the aqueous layer extracted with
CH2Cl2. The organic layer was washed with water, dried (MgSO4) and
concentrated. Column chromatography (SiO2, CH2Cl2/MeOH 96:4) gave 4a–b.
Compound 4a (36 mg, 91%): brown solid; IR (neat): 3443 (br, OH), 1737 (C@O);
UV/vis (CH2Cl2): 251 (20040), 309 (sh, 7600), 399 (1300), 410 (sh, 830), 422
(790), 479 (980); 1H NMR (400 MHz, CDCl3): 4.60–4.49 (m, 8H), 3.97 (m, 4H),
2.26 (br s, 1H), 2.09 (br s, 1H), 1.47 (t, J = 7 Hz, 6H). MALDI-TOF-MS: 1091.5 (8%,
[M+Na]+, calcd for C74H20O10Na: 1091.1), 1068.5 (100%, [M]+, calcd for
C
74H20O10: 1068.1). Compound 4b (61 mg, 74%): brown solid; IR (neat): 3450
(br, OH), 1740 (C@O). UV/vis (CH2Cl2): 306 (sh, 21900), 331 (sh, 7400), 397 (sh,
2350), 409 (sh, 1550), 421 (1450), 478 (sh, 1600). 1H NMR (400 MHz, CDCl3):
4.61–4.48 (m, 8H), 3.80 (m, 4H), 2.04 (m, 4H), 1.94 (br s, 2H), 1.46 (t, J = 7 Hz,
3H), 1.45 (t, J = 7 Hz, 3H); MALDI-TOF-MS: 1096.1 ([M]+, calcd for C76H24O10
:
1096.1).
14. A solution of DMAP (1.42 g, 11.60 mmol) in anhydrous CH2Cl2 (100 mL) was
added dropwise within 3 h to a stirred solution of 16 (1.56 g, 5.30 mmol) and
malonyl chloride (0.57 mL, 5.83 mmol) in anhydrous CH2Cl2 (480 mL). After
18 h, the mixture was filtered on a plug of SiO2 (CH2Cl2) and evaporated.
Column chromatography (SiO2, CH2Cl2/cyclohexane 80:20 to CH2Cl2) gave 17
(450 mg, 24%), 18 (290 mg, 15%) and 19 (60 mg, 3%). Compound 17: colorless
oil; IR (neat): 1735 (C@O); 1H NMR (400 MHz, CDCl3): 4.29 (t, J = 6 Hz, 4H),
3.86 (t, J = 6 Hz, 4H), 3.37 (s, 2H), 1.91 (m, 4H), 1.01 (s, 18H); 13C NMR
(100 MHz, CDCl3): 166.2, 61.6, 59.3, 42.5, 31.7, 27.8, 20.8. Compound 18:
colorless oil; IR (neat): 1736 (C@O); 1H NMR (400 MHz, CDCl3): 4.29 (t, J = 6 Hz,
8H), 3.90 (t, J = 6 Hz, 8H), 3.37 (s, 4H), 1.89 (m, 8H), 1.00 (s, 36H); 13C NMR
(100 MHz, CDCl3): 166.6, 62.4, 60.0, 41.6, 31.7, 27.8, 21.1; MALDI-TOF-MS:
720.9 ([M]+, calcd for C34H64O12Si2: 720.4). Compound 19: colorless oil. 1H
NMR (400 MHz, CDCl3): 4.22 (m, 12H), 3.84 (t, J = 6 Hz, 12H), 3.30 (s, 6H), 1.83
(m, 12H), 0.93 (s, 54H); 13C NMR (100 MHz, CDCl3): 166.6, 62.5, 60.1, 41.5,
31.7, 27.8, 21.1; MALDI-TOF-MS: 1103.5 (100%, [M+Na]+, calcd for
C
51H96O18Si3Na: 1103.6), 1081.5 (47%, [M+H]+, calcd for C51H97O18Si3: 1081.6).
15. DBU (5 equiv) was added to a solution of C60 (1 equiv), appropriate bis-
malonate (18 or 31, 1 equiv), and I2 (2.5 equiv) in toluene (2 mL/mg of C60).
After 1 h at room temperature, the resulting mixture was directly filtered on a
plug of SiO2 (toluene then CH2Cl2) and concentrated. Column chromatography
(SiO2, CH2Cl2/cyclohexane 50:50 to CH2Cl2) gave the corresponding fullerene
bis-adduct (21 or 32). Compound 21 (115 mg, 27%): brown glassy solid; IR
(neat): 1748 (C@O); UV/vis (CH2Cl2): 259 (84200), 323 (sh, 24700), 439 (2500),
476 (2100), 622 (sh, 250); 1H NMR (400 MHz, CDCl3): 4.71–4.62 (m, 4H), 4.50–
4.41 (m, 4H), 4.03 (m, 4H), 3.88 (m, 4H), 2.10 (m, 4H), 1.98 (m, 4H), 1.11 (s, 9H),
1.04 (s, 18H), 0.87 (s, 9H). 13C NMR (100 MHz, CDCl3): see Figure 4. MALDI-
TOF-MS: 1438.4 ([M+H]+, calcd for C94H61O12Si2: 1438.4). Compound 32
(212 mg, 39%): brown glassy solid; IR (neat): 1743 (C@O); UV/vis (CH2Cl2): 259
(88000), 323 (sh, 26200), 439 (2700), 476 (1300), 622 (sh, 280); 1H NMR
(400 MHz, CDCl3): 4.57 (m, 2H), 4.50 (m, 2H), 4.39 (m, 2H), 4.26 (m, 2H), 1.99
(m, 4H), 1.84 (m, 4H), 1.75 (m, 4H), 1.63 (m, 4H), 1.07 (s, 9H), 1.04 (s, 9H), 1.03
(s, 9H), 0.95 (s, 9H); 13C NMR (100 MHz, CDCl3): 146.3, 146.1, 145.8, 145.7,
145.5, 145.3, 145.0 (2C), 144.7, 144.6, 144.4 (2C), 144.2, 143.6 (2C), 143.5 (2C),
142.4, 141.3, 141.1, 140.1, 137.2, 136.4, 136.1, 135.7, 70.6, 67.7, 66.7, 63.2,
62.8, 50.3, 28.8, 28.5, 27.9, 27.8, 26.9, 25.5, 25.0, 21.4. MALDI-TOF-MS: 1493.3
([M+H]+, calcd for C98H69O12Si2: 1493.4).
16. DBU (0.15 mL, 1.00 mmol) was added to a solution of C60 (108 mg, 0.15 mmol),
19 (58 mg, 0.15 mmol), and I2 (131 mg, 0.52 mmol) in toluene (400 mL). After
1 h at room temperature, the resulting mixture was filtered on a plug of SiO2
(toluene then CH2Cl2) and concentrated. Column chromatography (SiO2,
CH2Cl2/cyclohexane 50:50 to CH2Cl2) gave 22 (55 mg, 61%) as a cherry-red
glassy solid; IR (neat): 1751 (C@O); UV/vis (CH2Cl2): 252 (169115), 281
(107581), 304 (sh, 86077), 482 (6208), 564 (sh, 1819); 1H NMR (400 MHz,
CDCl3): 4.70 (m, 3H), 4.60 (m, 3H), 4.36 (m, 6H), 3.95–3.77 (m, 12H), 1.94 (m,
12H), 0.98 (s, 36H), 0.90 (s, 36H); 13C NMR (100 MHz, CDCl3): see Figure 4;
MALDI-TOF-MS: 1797.0 ([M+H]+, calcd for C111H91O18Si3: 1796.5).
10. DBU (5 equiv) was added to a solution of C60 (1 equiv), appropriate bis-
malonate (2a or 2b; 1 equiv) and I2 (2.5 equiv) in toluene (2 mL/mg of C60) at
ꢁ15 °C. After 1 h at ꢁ15 °C, the resulting mixture was directly filtered on a plug
of SiO2 (first eluted with toluene to eliminate the unreacted C60 then with
CH2Cl2) and concentrated. Column chromatography (SiO2, CH2Cl2/cyclohexane
3:2) gave the corresponding fullerene bis-adduct (3a or 3b). Compound 3a
(59 mg, 23%): dark brown solid; IR (neat): 1744 (C@O); UV/vis (CH2Cl2): 310
(sh, 34800), 368 (sh, 9900), 398 (sh, 3900), 410 (sh, 2500), 421 (2400), 479
(2700); 1H NMR (300 MHz, CDCl3): 4.77 (m, 1H), 4.58–3.99 (m, 10H), 3.89 (m,
1H), 1.44 (t, J = 7 Hz, 6H), 1.09 (s, 9H) 0.94 (s, 9H). 13C NMR (75 MHz, CDCl3):
164.0, 163.6, 163.5, 163.1, 148.7, 147.4, 146.6, 146.5, 146.4, 146.3, 146.2, 145.8,
145.6, 145.5, 145.4, 145.3, 145.1, 145.0, 144.9, 144.8, 144.7, 144.6, 144.4, 144.2,
144.1, 143.9, 143.8, 143.7, 143.6, 143.5, 143.2, 143.1, 142.2, 142.1, 142.0, 141.8,
141.6, 141.5, 140.6, 140.4, 140.0, 139.8, 139.0, 138.6, 71.1, 70.4, 68.1, 66.7, 63.6,
63.5, 62.4, 60.8, 53.8, 51.2, 28.1, 27.7, 21.8, 21.4, 14.3; MALDI-TOF-MS: 1210.2
(100%, [M+H]+, calcd for C82H37O10Si: 1210.3), 1164.7 (21%, [MꢁOEt]+, calcd for
C
80H32O9Si: 1165.2). Compound 3b (332 mg, 48%): dark brown solid; IR (neat):
1751 (C@O); UV/vis (CH2Cl2): 310 (sh, 38670), 361 (sh, 13450), 398 (sh, 3850),
409 (sh, 2410), 421 (2260), 479 (sh, 2740); 1H NMR (300 MHz, CD2Cl2): 4.81–
4.71 (m, 2H), 4.57–4.36 (m, 6H), 3.98–3.84 (m, 4H), 2.06–1.96 (m, 4H), 1.44 (t,
J = 7 Hz, 6H), 1.06 (s, 9H), 0.94 (s, 9H); 13C NMR (75 MHz, CDCl3): 164.1, 163.6,
163.3 (2C), 148.8, 147.3, 147.0, 146.5, 146.4, 146.2, 146.1, 145.8, 145.5, 145.4,
145.3, 145.2, 145.1, 145.0, 144.9, 144.8, 144.7, 144.6, 144.5, 144.3, 144.1, 143.9,
143.7, 143.6, 143.5, 143.2, 143.1, 142.5, 142.0, 141.9, 141.8, 141.7, 141.5, 141.2,
140.5, 139.7, 138.8, 138.6, 71.7, 70.5, 64.2, 63.5, 63.4, 63.3, 60.4, 59.8, 54.0,
51.6, 32.2, 31.7, 27.8, 27.0, 21.3, 14.3; MALDI-TOF-MS: 1237.3 ([M+H]+, calcd
for C84H41O10Si: 1237.3).
11. BF3ꢀEt2O (20 equiv) was added to
a solution of the appropriate fullerene
derivative (3a–b; 1 equiv) in CH2Cl2/CH3CN (2:1) at room temperature. The